New Enterprise Associates

New Enterprise Associates (NEA) is a prominent venture capital firm established in 1977, headquartered in Menlo Park, California, with additional offices in the U.S., India, and China. NEA specializes in investing in technology and healthcare sectors, with a focus on enterprise, consumer, fintech, life sciences, and digital health companies. The firm engages with entrepreneurs at various stages of business development, providing support from initial funding to public offerings. NEA invests globally, with a significant presence in Asia, including China and India, as well as the United States. The firm typically invests between $0.05 million and $20 million per deal.

Michael Albert

Associate

Kate Barrett

Partner, Communications

Ron Bernal

Venture Partner

Ann Bordetsky

Partner

Zak Burns

Associate

James Buxton MD

Principal

Carmen Chang

Partner, Chair and Head of Asia

Tak Cheung

Partner

Philip Chopin

Managing Director, NEA UK

Pamela Clark

General Partner

Vanessa Deng

Associate

Chris Doppman

Principal, LP Relations

Tony Florence

General Partner

Scott Gottlieb

Partner

Jay Graf

Venture Partner

Lily Huang

Principal, Healthcare VC

Aaron Jacobson

Partner

Arjun Jain

Senior Associate

James Kaplan

Associate

Nick Kline

Principal, LP Relations

Vanessa Larco

Partner

Danielle Lay

Principal

Tiffany Le

Principal

Michael Li

Principal

Tiffany Luck

Partner

Matthew McAviney

Partner

Amit Mukherjee

Partner

Bibhash Mukhopadhyay

Principal

Kemi Odusan

Senior Associate

Jess Ou

Senior Associate

Greg Papadopoulos

Venture Partner

Luke Pappas

Principal

Eileen Qian

Associate

Tim Schaller

CFO

Alex Sharata

Associate

George Stamas

Venture Partner

Brad Thawley

Partner, Limited Partner Relations

Lila Tretikov

Partner

Paul Walker

General Partner

Blake Wu

Partner

Lulu Xu

Principal

Rick Yang

Partner, Head of Technology

Emily Zhen

Associate

Arno Penzias Ph.D

Venture Partner

J.C. Lopez

Principal

Past deals in Growth Stage

Chaos

Series C in 2025
Chaos Industries is a technology company specializing in next-generation solutions for defense and critical industries. The company is dedicated to enhancing sensing, detection, and communication capabilities through the use of Coherent Distributed Networks (CDN). Its focus on detection and radar services supports the development of advanced defense products, allowing clients to access high-quality services tailored to their needs.

Vori Health

Series B in 2025
Vori Health is a healthcare provider focused on treating musculoskeletal conditions through an integrated care delivery model. Founded in 2020 and headquartered in New York, the organization offers a comprehensive range of services, including physical therapy, medical assessments, lab and imaging orders, health coaching, and nutritional guidance. Vori Health employs a virtual-first approach to connect patients with a collaborative care team, consisting of board-certified physical medicine physicians, health coach navigators, and physical therapists. This model aims to facilitate effective management of back, neck, and joint issues, guiding patients toward optimal wellness and recovery. By combining evidence-based practices with personalized support, Vori Health strives to improve patient outcomes in musculoskeletal care.

Metronome

Series C in 2025
Metronome is a billing infrastructure company that specializes in supporting software companies with usage-based business models. The company's platform provides metering and data mediation software, ensuring a robust data infrastructure and real-time architecture for effective billing. Metronome emphasizes rapid deployment and user-friendliness, allowing business and product teams to manage revenue and pricing with minimal engineering effort. After integrating the platform, teams can swiftly introduce new products and pricing structures, streamline revenue workflows, and offer customers immediate visibility into their spending. This flexibility enables companies to efficiently launch, iterate, and scale their operations.

Abcuro

Series C in 2025
Abcuro, Inc. is a biotechnology company focused on developing immunotherapies for the treatment of autoimmunity and cancer. Based in Newton, Massachusetts, Abcuro creates therapeutic antibodies targeting novel mechanisms related to these diseases. The company utilizes advanced bioinformatics to analyze transcription data from human diseases, which aids in the identification of new therapeutic targets. Through ex-vivo validation in diseased tissues, Abcuro seeks to uncover innovative methods to modulate key components of the immune system. Established in 2015, Abcuro aims to enhance treatment strategies in the healthcare industry by offering effective solutions for complex immunological conditions.

Tune Therapeutics

Series B in 2025
Tune Therapeutics is focused on developing innovative cell and gene therapies that utilize epigenetic programming to address serious diseases. By harnessing the epigenome, the company aims to create new pathways for treatment without making changes to the DNA sequence itself. This approach allows for the potential development of therapies for complex and widespread medical conditions, positioning Tune Therapeutics at the forefront of advancements in the field of epigenetics.

Sana

Series C in 2024
Sana is an AI company building AI for enterprise knowledge.

Pathos

Series C in 2024
Pathos is a company that focuses on enhancing the drug discovery process through its AI-enabled platform. This self-learning technology leverages big data and artificial intelligence to streamline the identification and validation of drug targets, ultimately establishing their clinical efficacy. By facilitating the exploration of novel concepts, Pathos aims to support drug developers in advancing innovative therapies. The platform is designed to manage the entire end-to-end process of designing and developing new therapeutics, thereby significantly reducing the time required for medication development.

858 Therapeutics

Series B in 2024
858 Therapeutics is a biotechnology company dedicated to the discovery of small molecule therapeutics aimed at treating cancers and other diseases, particularly those resistant to existing therapies. The company employs innovative strategies in areas such as synthetic lethality, innate immunity, and RNA modulation to develop its therapeutic candidates. Its lead program focuses on a PARG inhibitor, which is currently in early clinical development. By leveraging its platform to investigate the role of RNA modifying proteins in disease biology, 858 Therapeutics is generating a pipeline of targeted small molecules that address critical unmet medical needs in oncology and immunology.

Second Front

Series C in 2024
Second Front Systems, Inc. is a software development company based in Arlington, Virginia, that focuses on enhancing government access to venture capital-backed technologies for national security missions. Established in 2014, the company offers Atlas Fulcrum, a platform that helps users identify, assess, and utilize innovative commercial technologies. Additionally, Second Front provides program management and system integration services to facilitate the delivery of technology to military personnel. The High Technology Council, an enterprise consortium established by the company, brings together key industry players to leverage commercially developed technologies for government-funded national security efforts. Second Front also specializes in configuring, securing, and deploying compliant software applications for global government customers, ensuring that users have access to a fully managed production environment tailored for national security applications.

PayZen

Series B in 2024
PayZen is a healthcare fintech startup founded in 2019 in San Francisco by Ariel Rosenthal, Itzik Cohen, and Tobias Mezger. The company addresses the challenge of patient payment responsibilities by providing a platform that allows patients to pay their out-of-pocket medical bills over time, enhancing convenience and transparency. PayZen's technology utilizes artificial intelligence to create tailored payment plans that cater to individual financial situations, thereby improving affordability for patients. This approach not only facilitates timely payments but also helps medical providers optimize cash flow and minimize the costs associated with collecting outstanding invoices. By focusing on patient financing solutions, PayZen enables healthcare providers to concentrate on delivering medical care rather than managing financial transactions.

MBX Biosciences

Series C in 2024
MBX Biosciences, Inc. is a biotechnology company based in Carmel, Indiana, specializing in the development of therapeutics for rare endocrine disorders. Established in 2018, the company focuses on creating peptides aimed at treating genetic diseases that affect glandular hormones, which play a crucial role in the body’s chemical messaging system. By targeting conditions with inadequate treatment options, MBX Biosciences is dedicated to discovering, developing, and commercializing innovative endocrine therapeutics.

Cardurion Pharmaceuticals

Series B in 2024
Cardurion Pharmaceuticals, LLC is a biotechnology company based in Boston, Massachusetts, established in 2017. The company specializes in developing innovative therapeutics aimed at treating heart failure and other cardiovascular diseases. Cardurion is advancing clinical programs that focus on inhibiting PDE9 and CaMKII, utilizing its knowledge of cardiovascular signaling pathways to meet significant patient needs in this area.

Zenas BioPharma

Series C in 2024
Zenas BioPharma is a clinical-stage biopharmaceutical company based in Florida, dedicated to developing immune-based therapies for patients. The company's lead product candidate, obexelimab, is a bifunctional monoclonal antibody that targets both CD19 and FcγRIIb, which are found on B cells. This innovative approach aims to inhibit the activity of B cells involved in various autoimmune diseases while preserving their overall population, thus offering a potential therapeutic advantage over traditional treatments that deplete these cells.

SafeBase

Series B in 2024
SafeBase, Inc. is a San Francisco-based company founded in 2020 that specializes in cloud-based security software aimed at helping organizations establish and enhance their security programs. The company’s offerings include a smart trust center platform that facilitates the sharing of security posture and automates access to sensitive documents. SafeBase provides solutions such as SafeBase Inspected, which features a website badge linking to a custom security status page, as well as custom security checklists and continuous monitoring of security systems. Additionally, the software assists organizations in configuring security policies, thereby enabling them to implement robust security practices effectively.

Beehiiv

Series B in 2024
Beehiiv is an email newsletter platform that empowers creators to produce, monetize, and expand their newsletters. The platform enhances audience engagement and growth through advanced customization and superior analytics, allowing users to effectively scale their web and email content. Beehiiv's direct engagement model reduces reliance on cookie-based data, providing a more reliable method for publishers and advertisers to connect with their audiences. Notably, the company does not take a share of subscription revenue, offering a more lucrative financial model for creators looking to maximize their earnings.

Perplexity

Venture Round in 2024
Perplexity is an artificial intelligence-based search engine platform that combines large language models with traditional search engines. It leverages natural language processing and generative AI technologies to deliver conversational responses to user queries, aiming to enhance the search experience beyond standard results. The platform is designed to facilitate the development of safe and beneficial artificial general intelligence, offering an open-source environment accessible to the public. This allows clients to acquire skills and knowledge in software development, positioning Perplexity as a bridge between conventional search capabilities and advanced AI-driven assistance.

Lily AI

Series B in 2024
Lily AI is a developer of an e-commerce product discovery platform that enhances the sales capabilities of brands and retailers. The platform integrates customer-centric product attributes into various components of the e-commerce ecosystem, including site search engines, recommendation systems, and SEO/SEM functionalities. By improving on-site search and personalized product discovery, Lily AI supports retailers in the fashion, home, and beauty sectors, leading to significant increases in traffic, conversion rates, revenue, and brand loyalty. Headquartered in Mountain View, California, the company is backed by venture capital.

Inkitt

Series C in 2024
Inkitt GmbH operates an online community that connects writers and readers, facilitating the sharing and promotion of stories across various genres, including horror, romance, and sci-fi. Founded in 2013 and based in Berlin, the company publishes books using crowd wisdom and data-driven insights to predict future bestsellers. Its core platform, Inkitt, allows authors to share their works in progress and receive feedback from readers, who can access these manuscripts for free for a limited time. In addition to Inkitt, the company also operates Galatea, which sells optimized stories in a chapter-by-chapter format, and GalateaTV, which adapts successful e-books into short-form television series. Inkitt's proprietary ReadRank algorithm identifies high-potential stories, enhancing the overall user experience and driving its publishing success. The company aims to leverage AI for hyper-personalization, tailoring stories to individual reader preferences across multiple media formats.

Metronome

Series B in 2024
Metronome is a billing infrastructure company that specializes in supporting software companies with usage-based business models. The company's platform provides metering and data mediation software, ensuring a robust data infrastructure and real-time architecture for effective billing. Metronome emphasizes rapid deployment and user-friendliness, allowing business and product teams to manage revenue and pricing with minimal engineering effort. After integrating the platform, teams can swiftly introduce new products and pricing structures, streamline revenue workflows, and offer customers immediate visibility into their spending. This flexibility enables companies to efficiently launch, iterate, and scale their operations.

Comanche Biopharma

Series B in 2024
Comanche Biopharma is a biopharmaceutical company focused on developing an investigational small interfering RNA (siRNA) medicine aimed at treating preterm preeclampsia. The company is committed to ensuring that all women and their babies have access to safe and effective therapies for life-threatening complications during pregnancy. Comanche Biopharma's mission emphasizes the importance of evidence-based and affordable solutions, enabling women to receive cost-effective treatments that address the root causes of preeclampsia.

Perplexity

Series B in 2024
Perplexity is an artificial intelligence-based search engine platform that combines large language models with traditional search engines. It leverages natural language processing and generative AI technologies to deliver conversational responses to user queries, aiming to enhance the search experience beyond standard results. The platform is designed to facilitate the development of safe and beneficial artificial general intelligence, offering an open-source environment accessible to the public. This allows clients to acquire skills and knowledge in software development, positioning Perplexity as a bridge between conventional search capabilities and advanced AI-driven assistance.

Second Front

Series B in 2023
Second Front Systems, Inc. is a software development company based in Arlington, Virginia, that focuses on enhancing government access to venture capital-backed technologies for national security missions. Established in 2014, the company offers Atlas Fulcrum, a platform that helps users identify, assess, and utilize innovative commercial technologies. Additionally, Second Front provides program management and system integration services to facilitate the delivery of technology to military personnel. The High Technology Council, an enterprise consortium established by the company, brings together key industry players to leverage commercially developed technologies for government-funded national security efforts. Second Front also specializes in configuring, securing, and deploying compliant software applications for global government customers, ensuring that users have access to a fully managed production environment tailored for national security applications.

Pair Eyewear

Series C in 2023
Pair Eyewear, founded in 2017 and based in New York, specializes in customizable eyeglasses for children. The company offers a unique product line that includes base frames, which are standard glasses, and top frames, which are snap-on fronts that can be easily changed to reflect a child's evolving interests and personalities. By leveraging an e-commerce platform, Pair Eyewear aims to transform the eyeglass experience into an engaging activity for children while simplifying the process for parents. The brand focuses on quality and affordability, providing eyewear that combines style with functionality, featuring hand-polished acetate frames and shatterproof polycarbonate lenses.

Pulumi

Series C in 2023
Pulumi Corporation operates an infrastructure-as-a-code platform that facilitates the development, deployment, and management of cloud applications and infrastructure. Founded in 2017 and based in Seattle, Washington, Pulumi offers the Pulumi SDK, an open-source tool that enables developers and DevOps teams to utilize programming languages for defining and managing cloud services across various environments, including public, private, and hybrid clouds. The platform supports a range of application types, from serverless functions to containerized applications, and emphasizes collaboration among teams to streamline cloud engineering processes. By providing a consistent workflow for delivering and securing applications, Pulumi helps businesses effectively create modern applications and manage their cloud environments.

Fizz

Series B in 2023
Fizz is an authorized platform designed to enhance community social structures, particularly within institutions. It develops online social media software that facilitates communication and the sharing of ideas, events, and experiences among users. The platform allows individuals to post secret confessions and ask questions within a closed community, promoting social interaction while maintaining anonymity. By leveraging these features, Fizz aims to foster a more connected and engaged community environment.

SpyGlass Pharma

Series C in 2023
Spyglass Pharma specializes in developing innovative treatments for chronic ophthalmic diseases, leveraging advanced technology to enhance patient care and vision. The company focuses on creating ophthalmic devices and a drug delivery platform that addresses unmet needs in areas such as cataracts and lens replacement surgeries. Its delivery system is designed to be implanted alongside intraocular lenses during standard cataract procedures, allowing surgeons to administer multi-year therapies for chronic conditions. This approach aims to improve the accessibility and affordability of quality eye treatments for patients, ensuring better outcomes in ophthalmic care.

Instabase

Series C in 2023
Instabase, Inc. is a technology company based in San Francisco, California, founded in 2015. It specializes in developing a platform that automates document processing workflows and analyzes unstructured data. The platform integrates various capabilities, including optical character recognition, data classification and extraction, and natural language processing, allowing organizations across sectors such as insurance, finance, and healthcare to streamline operations and improve decision-making. Additionally, Instabase provides a developer kit that enables the creation of customized business applications, helping institutions embed artificial intelligence into their systems and processes. Through its innovative solutions, Instabase aims to address significant business challenges and facilitate transformational outcomes for its clients.

Strive Health

Series C in 2023
Strive Health, LLC, founded in 2018 and based in Denver, Colorado, specializes in solutions for chronic kidney disease. The company operates dialysis centers and employs a technology-enhanced clinical model to improve patient outcomes and experiences. Strive Health works collaboratively with innovative payers and providers to transform kidney care by focusing on the entire healthcare journey of chronic kidney disease patients, from primary care engagement to dialysis treatment. The company utilizes predictive analytics and comparative data to identify at-risk patients and aims to reinvent primary care to address kidney disease proactively, reducing the need for inpatient services and promoting home dialysis options. Backed by notable investors, Strive Health is committed to enhancing the management and care of patients with chronic kidney disease.

Sana

Series B in 2023
Sana is an AI company building AI for enterprise knowledge.

Weaviate

Series B in 2023
Weaviate is a developer of an open-source AI platform that specializes in creating search and recommendation systems. The company's hybrid SaaS platform features a powerful AI vector search engine, which is designed to handle various use cases, including semantic search. It also includes plugins for integration into different applications and a user-friendly console for data management. Weaviate's architecture allows for efficient scaling, supporting the deployment of machine learning models and handling billions of data objects. This capability enables clients to leverage advanced search functionalities and enhance their applications with effective recommendation systems.

Mojo Vision

Series C in 2023
Mojo Vision Inc. is a company based in Saratoga, California, established in 2015, that specializes in augmented reality technology. The firm is focused on developing high-performance micro-LED displays for various applications, including consumer, enterprise, and government sectors. It has created the world's smallest and densest dynamic display integrated into a smart contact lens, designed to provide users with timely information without disrupting their focus. This innovative product allows for hands-free connectivity and access to relevant information, thereby minimizing reliance on traditional mobile devices. Additionally, Mojo Vision has formed a joint development agreement with Menicon Co., Ltd. to explore smart contact lens products further, leveraging its advanced micro-LED technology and manufacturing processes to disrupt the display industry.

Workera

Series B in 2023
Workera is a precision upskilling platform that enables enterprises, governments, and individuals to enhance their technological capabilities in areas such as data science, machine learning, and artificial intelligence. The platform utilizes artificial intelligence to offer a detailed assessment of workforce skills, providing hyper-personalized learning plans tailored to individual needs. This approach helps organizations identify skill gaps and mobilize talent effectively, ensuring they remain competitive in a rapidly evolving landscape. Through AI-driven mentorship and adaptive assessments, Workera delivers measurable results that facilitate upskilling and reskilling efforts, ultimately supporting informed decision-making in talent acquisition and development.

Fabric8Labs

Series B in 2023
Fabric8Labs, Inc., founded in 2015 and based in La Jolla, California, specializes in non-thermal metal 3D printing technology. The company has developed a distinctive process that combines stereo-lithography and electro-deposition, providing an innovative alternative to traditional powder bed fusion methods. This technology eliminates the need for metal powders, vacuum chambers, and lasers, which significantly reduces manufacturing costs. Moreover, Fabric8Labs' approach enhances material quality and simplifies the additive manufacturing process by utilizing cartridges that ensure safety during production and facilitate easy disposal of used salt cartridges. Through these advancements, Fabric8Labs aims to revolutionize the landscape of metal 3D printing.

Crowdbotics

Series B in 2023
Crowdbotics Corporation is a software development company that provides an application builder platform aimed at streamlining the creation and deployment of web and mobile applications. Founded in 2016 and based in Richmond, California, Crowdbotics enables product managers and developers to transform ideas into functional code by utilizing a comprehensive library of millions of production-grade software components. The platform employs systematic code reuse and artificial intelligence to match specific application requirements with existing code modules, enhancing efficiency and reducing risk. Additionally, Crowdbotics offers ongoing support services, including infrastructure management, implementation, maintenance, monitoring, and security for applications throughout their lifecycle, which allows businesses to focus on achieving their objectives while minimizing development time.

Outrider

Series C in 2023
Outrider, Inc. is a software company that specializes in automating logistics hubs through the use of electric, self-driving trucks. Established in 2017 and based in Golden, Colorado, Outrider provides a software-as-a-service (SaaS) solution designed for customer-owned freight and transportation fleets. The company offers a comprehensive system comprised of web-based management software, autonomous driving controls for electric yard trucks, and necessary site infrastructure. Its technology automates various yard operations, including the movement of trailers and the engagement and disengagement of trailer connections, thereby eliminating hazardous and repetitive manual tasks. By focusing on the development of zero-emission systems, Outrider aims to enhance safety and efficiency for large enterprises reliant on logistics.

Escient Pharmaceuticals

Series C in 2022
Escient Pharmaceuticals is a biotechnology company based in San Diego, California, that develops and manufactures drugs targeting G protein-coupled receptors (GPCRs) for the treatment of neuro-immuno-inflammatory and autoreactive diseases. Founded in 2017, the company specializes in harnessing the therapeutic potential of specific orphan GPCRs, particularly the Mas-Related G-Protein Receptors (Mrgprs), to address various neurosensory-inflammatory disorders. Escient's innovative approach aims to provide first-in-class therapies for conditions associated with mast cell-mediated disorders and cholestatic pruritus, thereby expanding treatment options for healthcare providers and patients facing these challenging diseases.

Dandelion Energy

Series B in 2022
Dandelion Energy, Inc. is a Palo Alto, California-based company founded in 2017 that specializes in affordable geothermal heating and cooling solutions. The company replaces traditional air conditioning and heating systems with an innovative home geothermal system that utilizes a powerful heat pump and underground pipes to transfer heat between the earth and the residence. This system is designed to harness thermal energy from below the earth's surface to regulate indoor temperatures and provide hot water, allowing homeowners to transition from conventional heating fuels to a more sustainable geothermal alternative. Dandelion Energy is committed to making renewable heating and cooling accessible and cost-effective for homeowners.

MBX Biosciences

Series B in 2022
MBX Biosciences, Inc. is a biotechnology company based in Carmel, Indiana, specializing in the development of therapeutics for rare endocrine disorders. Established in 2018, the company focuses on creating peptides aimed at treating genetic diseases that affect glandular hormones, which play a crucial role in the body’s chemical messaging system. By targeting conditions with inadequate treatment options, MBX Biosciences is dedicated to discovering, developing, and commercializing innovative endocrine therapeutics.

Merge

Series B in 2022
Merge provides a comprehensive platform for B2B companies to streamline their integration processes through a single application programming interface (API). Founded in 2020, the company specializes in offering Unified APIs that facilitate secure data access across various software categories, such as human resources, accounting, customer relationship management, and file storage. Merge manages the complete integration lifecycle, from a swift initial setup to ongoing maintenance and observability tools, ensuring customer satisfaction. Its services help businesses enhance their operational efficiency by reducing customer churn, accelerating product development, and lowering engineering costs. Based in San Francisco, New York City, and Berlin, Merge has garnered significant support, receiving $75 million in funding from notable investors.

Inversago Pharma

Series C in 2022
Inversago Pharma Inc. is a preclinical-stage biotechnology company based in Montreal, Canada, focused on developing innovative therapies targeting metabolic and fibrotic disorders. The company specializes in peripherally-restricted CB1 receptor inverse agonists, which aim to offer new treatment options for conditions such as Prader-Willi syndrome, diabetes, and related metabolic disorders. Inversago Pharma's research includes addressing complications associated with diabetic kidney disease, non-alcoholic steatohepatitis, and various fibrotic diseases, including interstitial lung disease. Founded in 2015, the company is dedicated to enhancing patient outcomes through its pioneering approach to CB1 blockade.

Theorycraft Games

Series B in 2022
Theorycraft Games operates as an independent game development studio that operates remotely. The company is in process of developing its first game codenamed Loki. Theorycraft was founded in 2020 and is headquartered in Los Angeles, California, United States.

Ledgy

Series B in 2022
Ledgy is a Swiss company founded in 2017 by Ben Brandt, Timo Horstschaefer, and Yoko Spirig, specializing in a platform for managing equity capital and employee participation. The platform offers a streamlined approach to overseeing vesting plans, phantom programs, and numbered shares, enhancing transparency in the equity management process. By digitizing these elements, Ledgy provides entrepreneurs and shareholders with valuable insights into their capital tables, funding rounds, and exit negotiations, facilitating better decision-making and clarity for all stakeholders involved.

Evident

Venture Round in 2022
Evident is a leading provider of business credentialing solutions, operating a comprehensive platform that connects insurers and enterprises with millions of businesses globally. The company specializes in managing identity and credential verification, utilizing advanced AI to streamline the verification process while ensuring compliance with regulatory standards. Its platform is designed to identify and mitigate third-party risks across multiple domains, offering data-driven insights and a customizable framework to meet the specific needs of clients. By facilitating rigorous credentialing, Evident empowers businesses to monitor and manage risks effectively, enhancing their operational efficiency and compliance capabilities.

Moximed

Series C in 2022
Moximed, Inc. is a medical technology company based in Hayward, California, focused on developing innovative solutions for patients with knee osteoarthritis. The company offers the Atlas System, an implantable joint unloader designed to alleviate pain for individuals suffering from medial compartment knee osteoarthritis. This system operates similarly to a shock absorber, providing dynamic load reduction to minimize joint pain and enhance mobility. Moximed also features the MISHA Knee System, which offers an outpatient treatment option for patients who have not found relief through other therapies and are not suitable candidates for knee replacement surgery. By addressing the specific needs of osteoarthritis patients, Moximed aims to improve their quality of life while potentially delaying the need for more invasive surgical interventions. Founded in 2006, the company serves patients and medical professionals worldwide.

Snowplow

Series B in 2022
Snowplow is an enterprise-grade event analytics platform that specializes in behavioral data management. It empowers data teams by providing tools to track, contextualize, validate, and model customer interactions on websites and applications. The platform integrates web analytics with various third-party data sources, allowing businesses to gain comprehensive insights into customer behavior. Snowplow's solutions facilitate customer journey analytics, marketing attribution, product analytics, and paywall optimization, addressing complex data challenges and enhancing overall data-driven decision-making for organizations.

Narmi

Series B in 2022
Narmi Inc. is a technology company based in New York that specializes in developing online and mobile banking applications for financial institutions across the United States. Founded in 2016, Narmi focuses on providing regional and community banks and credit unions with a platform that streamlines account opening processes, allowing clients to complete this in under 2.5 minutes. The company’s offerings include features such as fraud protection, multi-factor authentication, and transaction monitoring, which help enhance security and user experience. In addition to banking applications, Narmi also provides website design, development, and hosting services, as well as content generation and management solutions. Their goal is to enable financial institutions to attract, engage, and retain customers through an intuitive, omnichannel banking experience.

Wonder

Series B in 2022
Wonder is a technology company that specializes in gaming and food delivery services. It offers an all-in-one gaming platform for Android mobile devices, enabling users to play, stream, and share games across various devices. Additionally, Wonder operates a food delivery service using trucks that function as mobile restaurants. Customers order food through a mobile app, and the Wonder trucks drive to a location near the user's home to prepare and deliver fresh meals on-site.

Lily AI

Venture Round in 2022
Lily AI is a developer of an e-commerce product discovery platform that enhances the sales capabilities of brands and retailers. The platform integrates customer-centric product attributes into various components of the e-commerce ecosystem, including site search engines, recommendation systems, and SEO/SEM functionalities. By improving on-site search and personalized product discovery, Lily AI supports retailers in the fashion, home, and beauty sectors, leading to significant increases in traffic, conversion rates, revenue, and brand loyalty. Headquartered in Mountain View, California, the company is backed by venture capital.

Super

Series C in 2022
Super is a social commerce platform that enables leaders to become self-made entrepreneurs and builds logistics networks. The company features Superagen, an agent-led commerce group buying that enables community leaders to become retailers within their communities.

Assembled

Series B in 2022
Assembled, Inc. operates a workforce management platform designed to enhance customer support operations for modern organizations. Founded in 2018 and based in San Francisco, California, the platform automates contact forecasting and staffing calculations while generating real-time productivity reports. It enables teams to efficiently forecast support volumes and create appropriate staffing plans, replacing the need for cumbersome spreadsheets and internal tools. Assembled features an intuitive team calendar that accommodates different time zones and specializations, allowing seamless integration with tools like Google Calendar and Slack for individual user interaction. Additionally, it provides visibility into support schedules and key metrics, such as response times, across all organizational levels. By facilitating the management of inbound support queries across multiple channels, including chat, email, phone, and social media, Assembled empowers organizations to optimize their customer support services.

Mashgin

Series B in 2022
Mashgin Inc. specializes in manufacturing intelligent kiosks that facilitate self-checkout at various retail environments, including cafés, convenience stores, and specialty shops. Founded in 2013 and based in Mountain View, California, the company utilizes advanced computer vision and deep learning technologies to streamline the checkout process. Its kiosks can recognize and process multiple items simultaneously, allowing customers to scan products based on their visual features such as color, shape, and size. This innovative system can be deployed quickly and at a lower cost compared to other self-checkout solutions. Currently, Mashgin's technology is in use at hundreds of locations, serving tens of thousands of customers daily.

Genies

Series C in 2022
Genies, Inc. is a company specializing in avatar technology, enabling users to create personalized digital avatars for social media and messaging applications. By offering tools for designing avatars, avatar wearable fashion, and interactive experiences, Genies allows individuals to express their thoughts and feelings in a unique digital format. The company has gained significant traction among cultural influencers and has partnered with major music labels, serving as the official avatar provider for their artists. Genies has also launched consumer offerings, including an AR Developer Kit that facilitates the creation of interoperable avatar experiences in augmented reality. Their initial product, Silver Studio, allows users to design and trade digital fashion items. Founded in 2011 and headquartered in Venice, California, Genies has successfully raised substantial investment, positioning itself as a leader in the avatar space and driving engagement for brands through the sale of exclusive digital goods.

Built Robotics

Series C in 2022
Built Robotics Inc. is a technology company focused on automating the construction industry through the development of AI guidance systems that transform heavy equipment into autonomous robots. Founded in 2016 and headquartered in San Francisco, California, the company integrates various sensors, including GPS, cameras, and Lidar, with advanced software to enable earthmoving equipment to operate autonomously. Built Robotics aims to address the workforce gap in the construction sector, particularly in the $300 billion solar industry, by automating repetitive tasks and facilitating the construction of critical infrastructure such as wind farms, oil and gas pipelines, and new housing developments.

ForAllSecure

Series B in 2022
ForAllSecure specializes in advanced fuzz testing and autonomous cybersecurity solutions, leveraging patented technology developed through extensive research at Carnegie Mellon University. The company collaborates with Fortune 1000 clients across sectors such as aerospace, automotive, and high-tech to deliver scalable security testing that adapts to rapid development and deployment cycles. Its innovative approach employs automated program analysis and artificial intelligence to identify and resolve software vulnerabilities in real-time, thereby enhancing the security posture of organizations. Recognized for its achievements, ForAllSecure won DARPA's Cyber Grand Challenge and was highlighted by MIT Technology Review as one of the 50 Smartest Companies.

Timescale

Series C in 2022
Timescale, Inc., established in 2011 and headquartered in New York with offices in Stockholm and Los Angeles, specializes in data analysis platforms designed for scale, ease of use, and complex queries. Its flagship product, TimescaleDB, is an open-source time-series database that supports full SQL, optimized for advanced analytics and production use cases. Timescale serves software developers and businesses worldwide, enabling them to build and analyze time-series and machine data applications.

Beyond Identity

Series C in 2022
Beyond Identity, Inc. offers a cloud-native passwordless identity management platform that enhances secure authentication by replacing traditional passwords with X.509-based certificates. Founded in 2019 and based in New York, the company provides a comprehensive suite of features including frictionless login, biometric authentication, and Single Sign-On (SSO) integration for various users such as employees, contractors, and suppliers. Its innovative approach utilizes asymmetric-key cryptography to create a robust Chain of Trust, which incorporates user and device identities along with real-time security posture assessments for adaptive risk-based authentication. This technology not only improves security by eliminating credential-stuffing attacks but also facilitates increased business agility and efficiency, allowing organizations to adopt new business models and significantly reduce operational costs while achieving complete passwordless identity management.

Thunkable

Series B in 2022
Thunkable is a U.S.-based company that offers a platform for users to create mobile applications without extensive coding knowledge. Originating from MIT's App Inventor and participating in YCombinator's W2016 batch, Thunkable provides a free drag-and-drop interface that simplifies the app development process. Users can design applications using built-in templates and make real-time changes, which can be instantly previewed on their devices through the Thunkable mobile app. The platform supports automatic formatting for deployment across major operating systems, including Android and iOS, enabling individuals to build and publish native apps efficiently. By eliminating the need for large development tools or complex coding, Thunkable empowers users to create functional applications easily and share them directly with others or upload them to app stores.

FTX

Series C in 2022
FTX is a cryptocurrency exchange company that specializes in developing a professional trading platform, supporting features such as quarterly and perpetual futures, leveraged tokens, and OTC trading. It aims to cater to both professional trading firms and first-time users, offering an intuitive and robust trading environment. FTX was incubated by Alameda Research, ensuring it had industry order books from its inception. Additionally, FTX Ventures, its investment arm, provides equity and/or token investments to blockchain companies at various stages, supporting founders and maintaining their decision-making flexibility.

Virtru

Series C in 2022
Virtru is a data security company based in Washington, D.C., founded in 2012. It offers a data protection platform that enables organizations to secure sensitive information while ensuring ease of use. The platform supports compliance with various regulations, including HIPAA, FERPA, CJIS, and ITAR, allowing businesses to maintain control over their data throughout its lifecycle—from creation and storage to sharing and analysis. Virtru is known for its development of the Trusted Data Format (TDF), an open industry standard for persistent data protection. More than 20,000 organizations across diverse sectors rely on Virtru's privacy technologies to safeguard their data.

Smartcar

Series B in 2022
Smartcar, Inc. is a technology company based in Mountain View, California, founded in 2014. It specializes in developing a platform that connects vehicles with mobility applications, enabling businesses to integrate their services with connected cars. Smartcar's API provides a range of functionalities, including access to vehicle data such as battery status, odometer readings, and location, as well as the ability to lock and unlock vehicles remotely. By offering a developer-friendly interface and comprehensive documentation, Smartcar facilitates the seamless integration of its services into various tech stacks, allowing clients to manage vehicle tracking, EV charging, and other automotive-related features efficiently.

Aquabyte

Venture Round in 2022
Aquabyte, Inc. specializes in developing advanced monitoring systems for the fish farming industry, employing computer vision and machine learning technologies. Founded in 2017 and headquartered in San Francisco, California, with an office in Bergen, Norway, Aquabyte's smart camera system enables real-time applications such as detecting biomass, counting sea lice, and monitoring fish appetite. The accompanying web dashboard provides continuous metrics to enhance operational efficiency. By integrating these technologies, Aquabyte aims to reduce operational costs and fish mortality while promoting sustainability in aquaculture. The company’s innovative approach seeks to address the challenges faced by fish farms, ultimately contributing to a more efficient and environmentally friendly industry.

Korro Bio

Series B in 2022
Korro Bio Inc., established in 2018 and headquartered in Cambridge, Massachusetts, specializes in developing nucleic acid-based therapeutics targeting specific sequences in genetic code to treat rare diseases. The company's proprietary platform enables efficient and selective RNA editing, leveraging natural processes common to all multicellular organisms. Korro Bio aims to advance this technology to effect changes in protein structure and function across multiple tissues, expanding the reach of genetic medicines with additional precision and tunability by editing RNA instead of DNA.

Mojo Vision

Series B in 2022
Mojo Vision Inc. is a company based in Saratoga, California, established in 2015, that specializes in augmented reality technology. The firm is focused on developing high-performance micro-LED displays for various applications, including consumer, enterprise, and government sectors. It has created the world's smallest and densest dynamic display integrated into a smart contact lens, designed to provide users with timely information without disrupting their focus. This innovative product allows for hands-free connectivity and access to relevant information, thereby minimizing reliance on traditional mobile devices. Additionally, Mojo Vision has formed a joint development agreement with Menicon Co., Ltd. to explore smart contact lens products further, leveraging its advanced micro-LED technology and manufacturing processes to disrupt the display industry.

Incarey

Series C in 2021
InCarey is a comprehensive medical service platform based in Shanghai, China, founded in 2011. The company specializes in the management of patients with chronic and vertical diseases, integrating medical, pharmaceutical, and insurance resources to deliver a one-stop solution for long-term healthcare needs. Its cloud-based platform offers professional disease management services, facilitating one-on-one interactions between doctors and patients. Additionally, InCarey's e-commerce capabilities enable users to obtain medications for major diseases efficiently. The platform is designed to address the complexities of chronic disease management, providing innovative payment solutions and a streamlined approach to healthcare services.

Yumi

Series B in 2021
Yumi is a company that focuses on providing science-based meal delivery services for young children, aiming to help parents understand their children's nutritional needs. The company produces fresh, nutrient-dense, and low-sugar baby food products that cater to various age groups, ensuring that children receive adequate nutrition during their critical early years. In addition to baby food, Yumi offers vitamins designed to support brain development, making it a comprehensive resource for parents seeking healthy options for their children’s diets. Through its convenient meal delivery program, Yumi stands out as a leading choice for those prioritizing nutrition in early childhood.

Forethought

Series C in 2021
Forethought, established in 2017 and based in Palo Alto, California, specializes in developing AI models for question-answering and information retrieval. The company's flagship product, Agatha Answers, is a smart agent that integrates into customer support teams' workflows, providing real-time assistance, automating repetitive tasks, and offering predictive insights to enhance efficiency and productivity.

Pair Eyewear

Series B in 2021
Pair Eyewear, founded in 2017 and based in New York, specializes in customizable eyeglasses for children. The company offers a unique product line that includes base frames, which are standard glasses, and top frames, which are snap-on fronts that can be easily changed to reflect a child's evolving interests and personalities. By leveraging an e-commerce platform, Pair Eyewear aims to transform the eyeglass experience into an engaging activity for children while simplifying the process for parents. The brand focuses on quality and affordability, providing eyewear that combines style with functionality, featuring hand-polished acetate frames and shatterproof polycarbonate lenses.

UNION

Series B in 2021
UNION POS specializes in developing UNION TAB, a customizable iPad-based point of sale software tailored for bars and restaurants. Established in 2009 and headquartered in Austin, Texas, UNION POS focuses on meeting the unique needs of high-volume, high-touch venues. Their system offers a fast and intuitive interface that simplifies reporting and operational processes, allowing users to dedicate more time to customer engagement. The software includes features such as inventory management and loyalty programs, all supported by 24/7 live assistance and competitive processing fees. UNION POS aims to create a seamless experience that enhances operational efficiency while enabling businesses to concentrate on delivering exceptional service.

Jiandanxinli (aka Simple Psychology)

Series B in 2021
Simple psychology belongs to Beijing Zhujian Technology Co., Ltd. Simple psychology focuses on providing high-quality psychological services.

Anyscale

Series C in 2021
Anyscale, Inc. is a technology company based in Berkeley, California, founded by the creators of the open-source project Ray. It specializes in developing distributed programming platforms and tools that simplify the creation and scaling of artificial intelligence applications. Anyscale's software enables developers and machine learning engineers to effortlessly scale their applications from local environments to the cloud, eliminating the need for complex infrastructure. The company's framework allows users of varying skill levels to build and deploy compute-intensive applications efficiently, facilitating faster and more cost-effective market entry for AI products. Anyscale aims to enhance the end-to-end AI lifecycle, making it accessible for organizations to leverage AI technologies.

Block Renovation

Series C in 2021
Block Renovation is a home renovation platform that integrates design, construction labor, and materials to create a seamless renovation experience for homeowners and contractors. Founded by Koda Wang and Luke Sherwin, the company aims to simplify the often complex and confusing process of home renovations. By bringing design, sourcing, and project management together, Block Renovation provides homeowners with clarity on outcomes, quality, pricing, and timelines. This approach not only enhances the experience for homeowners looking to improve their living spaces but also offers a more efficient working method for contractors.

Contra

Series B in 2021
Contra is a professional networking platform based in San Francisco, California, founded in 2019 by Ben Huffman and Gajus Kuizinas. The platform is designed to empower users to work independently by providing access to flexible work opportunities through a community and referral network. By showcasing work portfolios, Contra enables freelancers and independent professionals to present their skills and attract potential clients, allowing them to earn a living on their own terms. The focus on independence and flexibility distinguishes Contra in the evolving landscape of professional networking.

Attest

Series B in 2021
Attest Technologies Ltd., established in 2015 and headquartered in London, UK, operates a global online consumer research platform. It offers businesses real-time, on-demand consumer insights through surveys, enabling them to make data-driven decisions across various aspects such as marketing, product development, and brand tracking. Attest's platform allows direct engagement with over 110 million consumers across 45 countries, providing international research and testing solutions. The company is backed by prominent investors, including NEA, and serves clients aiming to drive predictable growth and fill knowledge gaps.

Stride Health

Series C in 2021
Stride Health, Inc. operates a health benefits platform tailored for independent workers and part-time employees in the United States. The company provides a range of affordable health coverage options, including dental plans, doctor visits, and prescription insurance. By simplifying the enrollment process, Stride Health enables users to quickly select their most cost-effective health plans while also offering assistance from personal advisors to help navigate any complexities. Founded in 2013 and based in San Francisco, California, Stride Health was previously known as Covered, Inc. The company's mission is to make health insurance more accessible and manageable for those who may not have traditional employment benefits.

Embrace

Series B in 2021
Embrace offers a unified observability and error monitoring platform tailored for mobile application development. This platform enables engineers to effectively manage the complexities associated with mobile environments, allowing them to proactively analyze user interactions and identify issues with detailed behavioral and technical context. Embrace's solution provides instant access to user sessions, facilitating a comprehensive understanding of events leading up to errors. By tracking every user activity—such as views, taps, and network requests—Embrace eliminates guesswork in troubleshooting, enhancing performance and enabling developers to create superior mobile experiences. The company's focus on delivering unique datasets empowers teams to prioritize and resolve issues swiftly, ultimately supporting the development of better mobile applications in an increasingly fragmented technological landscape.

Clarifai

Series C in 2021
Clarifai, Inc. is a prominent provider of advanced artificial intelligence solutions specializing in image recognition, natural language processing, and audio recognition. Founded in 2013 by Matt Zeiler, Ph.D., the company develops a deep learning platform that enables organizations to convert unstructured data—such as images, videos, text, and audio—into structured data efficiently and accurately. Clarifai's image recognition technology is capable of detecting near-duplicates, categorizing objects, and tagging images, while also allowing users to search for similar images within extensive uncategorized collections through a combination of semantic and visual similarity. Additionally, the company offers a labeling tool called Labeler, which aids in dataset labeling, AI training, and model auto-scaling in production environments. Headquartered in New York, with an office in Tallinn, Estonia, Clarifai employs a distributed team across various countries, including the United States, Canada, Argentina, and India.

Inkitt

Series B in 2021
Inkitt GmbH operates an online community that connects writers and readers, facilitating the sharing and promotion of stories across various genres, including horror, romance, and sci-fi. Founded in 2013 and based in Berlin, the company publishes books using crowd wisdom and data-driven insights to predict future bestsellers. Its core platform, Inkitt, allows authors to share their works in progress and receive feedback from readers, who can access these manuscripts for free for a limited time. In addition to Inkitt, the company also operates Galatea, which sells optimized stories in a chapter-by-chapter format, and GalateaTV, which adapts successful e-books into short-form television series. Inkitt's proprietary ReadRank algorithm identifies high-potential stories, enhancing the overall user experience and driving its publishing success. The company aims to leverage AI for hyper-personalization, tailoring stories to individual reader preferences across multiple media formats.

Sisu

Series C in 2021
Sisu is a decision intelligence engine that allows users to efficiently and comprehensively utilize their cloud data. Companies such as Mastercard, Autodesk, Samsung, Upwork, Wayfair, Equinox, Udacity, and Gusto leverage Sisu to enhance their customer experiences, increase revenue growth, and reduce incident rates.

Pager

Series C in 2021
Pager, Inc. operates an on-demand service platform that connects patients with healthcare services in various settings, including their homes, offices, and hotels. The company offers a mobile application that addresses urgent care needs such as infections, fevers, and allergies, while also providing services like nurse chat, teleconsultations, screening, vaccinations, and prescription delivery. Pager aims to improve healthcare access and decision-making by employing a flexible platform that serves health plans and systems, enhancing consumer experience through information, guidance, and coordination. By integrating clinical and service teams with advanced technology, Pager facilitates triage, telemedicine, appointment scheduling, and health advocacy, fostering a comprehensive care experience. The company, incorporated in 2013 and based in New York, supports over 15 million covered lives in the United States and Latin America.

Allay Therapeutics

Series C in 2021
Allay Therapeutics is focused on developing innovative pain management solutions aimed at improving post-surgical recovery for patients. The company utilizes a proprietary technology platform that integrates validated non-opioid analgesics with biopolymers to create dissolvable therapeutic products. These products are designed to deliver targeted pain relief at the surgical site over extended periods, significantly longer than conventional pain treatments. Allay's lead investigational product, ATX101, is currently undergoing evaluation in a Phase 2 clinical trial for total knee arthroplasty surgeries. With a team of experienced entrepreneurs, scientists, and clinicians based in the San Francisco Bay Area and Singapore, Allay Therapeutics is dedicated to transforming the approach to pain management and addressing the limitations associated with opioid use.

Rapid Robotics

Series B in 2021
Rapid Robotics, Inc. is a manufacturer of automated cell robots based in San Francisco, California, established in 2019. The company focuses on providing robotic solutions for manufacturers facing labor shortages and the complexities of material handling. Its AI-driven, vision-based platform is designed to handle a variety of palletizing tasks, allowing for rapid deployment of robotic workcells that can adapt to changing business needs. By offering a Robotics-as-a-Service (RaaS) model, Rapid Robotics enables companies to enhance their operational capacity and predictability without the financial burden and complexities associated with traditional robotic ownership and maintenance. The company's technology can be implemented quickly, often within hours, and at a significantly lower cost compared to other automation systems, ultimately improving production margins through increased efficiency and quality.

Tulip Interfaces

Series C in 2021
Tulip Interfaces, Inc. specializes in creating applications for the manufacturing industry that enhance shop floor operations. Founded in 2012 and based in Somerville, Massachusetts, the company offers a no-code platform that allows organizations to integrate data from various sources, including sensors and existing equipment. This integration facilitates the creation of digital work instructions and provides real-time visibility into operations, including the performance of personnel and machinery. Tulip serves a diverse range of industries, including consumer electronics, pharmaceuticals, apparel, and medical devices, helping companies improve productivity, quality, and operational efficiency. By leveraging advanced technologies such as intelligent hardware sensors, computer vision, and machine learning, Tulip's platform enables organizations to digitally transform their operations and achieve better end-to-end traceability.

Woebot Health

Series B in 2021
Woebot Health is a digital mental healthcare provider that focuses on delivering personalized support through an innovative platform. This platform integrates advanced artificial intelligence and natural language processing with established therapeutic techniques to create engaging mental health tools. At the core of its offering is Woebot, a relational agent designed to provide continuous, empathic, and personalized care. By leveraging these technologies, Woebot Health enables individuals and businesses to access effective mental health support conveniently and seamlessly, fitting into everyday life and promoting overall well-being.

Block Renovation

Series B in 2021
Block Renovation is a home renovation platform that integrates design, construction labor, and materials to create a seamless renovation experience for homeowners and contractors. Founded by Koda Wang and Luke Sherwin, the company aims to simplify the often complex and confusing process of home renovations. By bringing design, sourcing, and project management together, Block Renovation provides homeowners with clarity on outcomes, quality, pricing, and timelines. This approach not only enhances the experience for homeowners looking to improve their living spaces but also offers a more efficient working method for contractors.

Shape Therapeutics

Series B in 2021
Shape Therapeutics, Inc. is a biotechnology company founded in 2018 and based in Seattle, Washington. The company specializes in RNA-editing gene therapy targeting neurodegenerative disorders, oncology, metabolic conditions, and rare genetic diseases. Its proprietary RNAfix technology enables precise editing of RNA using the body's natural cellular mechanisms, which minimizes risks associated with immunogenicity, cellular toxicity, and off-target DNA editing. Shape Therapeutics employs a comprehensive approach to RNA gene therapy, integrating innovative payload, delivery, and manufacturing platform technologies. This strategy aims to facilitate the development of effective treatments and potential cures for a wide range of diseases, with the goal of enhancing patient outcomes across the healthcare landscape.

Spiras Health

Series B in 2021
Spiras Health operates a healthcare organization focused on delivering specialized treatment to patients with complex chronic conditions in their homes. The company employs a multidisciplinary team of clinicians to provide home-based clinical services, which are enhanced by telehealth, two-way digital communications, and remote patient monitoring. This approach aims to improve patients' quality of life while minimizing the costs associated with unnecessary hospitalizations. Spiras Health is dedicated to offering compassionate and specialized care tailored to the needs of each patient, ensuring they receive the support necessary to manage their health effectively in a familiar environment.

ARRIS

Series C in 2021
ARRIS specializes in additive molding technology for creating advanced performance composites tailored for mass-market applications such as aerospace, automotive, and consumer products. The company’s innovative manufacturing process focuses on the precise alignment of continuous carbon fibers, allowing for the integration of electronic components and multifunctional materials into a single, topologically optimized part. This technology enables clients to leverage high-performance composites, enhancing the capabilities and efficiency of their products while meeting the demands of modern manufacturing.

Metabase

Series B in 2021
Metabase is an open-source analytics and business intelligence application founded in 2014 and based in San Francisco, California. The platform enables users to create dashboards and reports, facilitating the measurement, analysis, and sharing of data to address complex business challenges. Metabase offers various professional services, including managed hosting and support, as well as assistance with implementing customized analytics solutions. This enables organizations to track data trends over time, enhancing their decision-making processes.

Aetion

Series C in 2021
Aetion, Inc. is a healthcare analytics company that specializes in real-world evidence (RWE) and outcomes-based analytics solutions. Founded in 2012 and based in New York City, Aetion develops the Aetion Evidence Platform, which leverages everyday clinical and financial interactions within the healthcare system to generate critical insights about the effectiveness and value of medical treatments. This platform serves a diverse clientele, including life sciences companies, payers, providers, medical device manufacturers, and academic institutions, allowing them to analyze data from various sources such as claims, electronic health records, registries, and clinical trials. Aetion’s patented rapid-cycle analytics technology facilitates real-time collaboration among stakeholders, enabling them to make informed decisions and optimize patient care. The company has formed strategic partnerships with leading organizations, including McKesson, to enhance its offerings and expand its reach in the healthcare sector.

Timescale

Series B in 2021
Timescale, Inc., established in 2011 and headquartered in New York with offices in Stockholm and Los Angeles, specializes in data analysis platforms designed for scale, ease of use, and complex queries. Its flagship product, TimescaleDB, is an open-source time-series database that supports full SQL, optimized for advanced analytics and production use cases. Timescale serves software developers and businesses worldwide, enabling them to build and analyze time-series and machine data applications.

Affinia Therapeutics

Series B in 2021
Affinia Therapeutics Inc. is focused on developing gene therapies for various diseases, particularly those affecting the muscles and central nervous system. The company specializes in creating adeno-associated virus (AAV) vectors, leveraging advanced techniques in synthetic and systems biology, as well as high-throughput screening and tissue and single-cell resolution. Founded in 2019 and based in Waltham, Massachusetts, Affinia aims to address significant unmet medical needs by providing rationally designed gene therapies with improved properties. The company's innovative approach seeks to offer effective treatments for devastating conditions that currently lack adequate therapeutic options.

Genies

Series B in 2021
Genies, Inc. is a company specializing in avatar technology, enabling users to create personalized digital avatars for social media and messaging applications. By offering tools for designing avatars, avatar wearable fashion, and interactive experiences, Genies allows individuals to express their thoughts and feelings in a unique digital format. The company has gained significant traction among cultural influencers and has partnered with major music labels, serving as the official avatar provider for their artists. Genies has also launched consumer offerings, including an AR Developer Kit that facilitates the creation of interoperable avatar experiences in augmented reality. Their initial product, Silver Studio, allows users to design and trade digital fashion items. Founded in 2011 and headquartered in Venice, California, Genies has successfully raised substantial investment, positioning itself as a leader in the avatar space and driving engagement for brands through the sale of exclusive digital goods.

Willow

Series C in 2021
Willow Inc., established in 2014 and headquartered in Mountain View, California, specializes in the manufacture of wearable breast pumps for women. The company offers a range of products including milk bags, accessories such as flanges and tubes, and replacement parts. Willow's flagship product is an in-bra wearable breast pump designed to provide mothers with mobility and hands-free convenience during breastfeeding. The company also provides pumping bras, cases, and other breastfeeding essentials.

Arcellx

Series C in 2021
Arcellx is a clinical-stage biotechnology company focused on developing innovative cell therapies for patients with cancer and other incurable diseases. The company aims to enhance the safety, effectiveness, and accessibility of these therapies. Its lead product candidate, CART-ddBCMA, targets relapsed or refractory multiple myeloma and is currently undergoing a Phase 1 clinical study. This therapy has received multiple designations from the U.S. Food and Drug Administration, including Fast Track and Orphan Drug status. Additionally, Arcellx is advancing its controllable CAR-T therapy, ARC-SparX, through two clinical programs aimed at treating relapsed or refractory multiple myeloma and acute myeloid leukemia.

Cleo

Series C in 2021
Cleo is a family support system that employers offer working parents, by helping families navigate their journey from fertility, to pregnancy, to parenting of newborns, infants, toddlers, and children to age 5. Employers choose Cleo as a strategic partner to power their culture transformation and see increased employee retention, more diverse and inclusive workplaces, and reduced health claims. Cleo supports parents globally in 50+ countries and works with forward-thinking companies like eBay, LinkedIn, Uber, and Straus Family Creamery and many others. Cleo is headquartered in San Francisco and is backed by Felicis Ventures, Forerunner Ventures, Greylock Partners, and NEA. Learn more at hicleo.com.

Strive Health

Series B in 2021
Strive Health, LLC, founded in 2018 and based in Denver, Colorado, specializes in solutions for chronic kidney disease. The company operates dialysis centers and employs a technology-enhanced clinical model to improve patient outcomes and experiences. Strive Health works collaboratively with innovative payers and providers to transform kidney care by focusing on the entire healthcare journey of chronic kidney disease patients, from primary care engagement to dialysis treatment. The company utilizes predictive analytics and comparative data to identify at-risk patients and aims to reinvent primary care to address kidney disease proactively, reducing the need for inpatient services and promoting home dialysis options. Backed by notable investors, Strive Health is committed to enhancing the management and care of patients with chronic kidney disease.

Monte Rosa Therapeutics

Series C in 2021
Monte Rosa Therapeutics is a biotechnology company focused on developing innovative cancer therapeutics that utilize molecular glue degraders (MGDs) to modulate protein degradation pathways. By leveraging the body's natural mechanisms for protein destruction, these small molecule drugs selectively target and degrade disease-causing proteins. The company employs its QuEEN platform, which combines artificial intelligence and proprietary experimental tools, to identify relevant proteins for degradation. With a diverse library of over 50,000 MGD molecules, Monte Rosa's lead candidate, MRT-2359, specifically targets the translation termination factor protein GSPT1, showing promise for treating MYC-driven tumors. The company aims to advance its pipeline of pioneering therapies for cancer and other diseases.

Nuvolo

Series C in 2021
Nuvolo Technologies Corporation offers a cloud-based enterprise asset management platform designed to support the lifecycle management of assets in various sectors, including healthcare, manufacturing, and facilities management. Founded in 2013 and headquartered in Paramus, New Jersey, Nuvolo innovates on the ServiceNow platform to provide a user-friendly experience for mobile and online users. The company’s solutions encompass implementation, support, tracking, reporting, and analytics, aimed at optimizing operational efficiency and improving asset management. Nuvolo also emphasizes security, workflow automation, and accurate inventory data, making it a comprehensive choice for businesses looking to enhance their asset management capabilities. With additional offices in London, Sofia, and Pune, Nuvolo maintains a global presence through strategic partnerships with firms such as KPMG and Unisys.

Burrow

Series C in 2021
Burrow, Inc. is a New York-based furniture company that designs, manufactures, and supplies a range of home furnishings, including customizable sofas, sectionals, loveseats, armchairs, and ottomans, as well as tables, rugs, and various accessories. Founded in 2016, Burrow focuses on creating luxury furniture that is both easy to move and comfortable, utilizing sustainably-sourced hardwood and non-toxic, scratch- and stain-resistant fabrics. The company aims to reinvent the home furnishing experience by offering personalized and durable products that allow customers to avoid traditional retail markups. Burrow sells its items through physical showrooms in several states, including Washington, Massachusetts, Texas, and California, as well as through its online platform. The company's manufacturing facility is located in Mexico City, Mexico.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.